Le Lézard
Classified in: Health
Subjects: NPT, WOM, FVT, DEI

Susan G. Komen® Dallas North Texas MORE THAN PINK Walk Raises Money for Health Equity Among Those Most Impacted by Breast Cancer


DALLAS, Sept. 22, 2022 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, will hold an in-person Dallas North Texas MORE THAN PINK Walk to raise critical funds that support breast cancer patients and health equity programs, including Susan G. Komen's Stand for H.E.R? a Health Equity Revolution ? a focused initiative to decrease breast cancer disparities in the Black community. The Walk will be held on Saturday, October 22, 2022, at The Levy Event Plaza, in Irving.

"We look forward to creating a community for anyone impacted by breast cancer as we gather, in person, for this year's Walk. Funds raised from the MORE THAN PINK Walk will further Komen's ability to meet the needs of patients and advance our health equity revolution to break down barriers to quality, timely care that create poor breast health outcomes," said Sofia Olivarez, Executive Director at Susan G. Komen.

Komen is pleased to welcome returning presenting sponsor this year is Tom Thumb/Albertsons Foundation.

Participants can expect to enjoy the following at the Walk:

Komen MORE THAN PINK Walk
The Levy Event Plaza
501 E Las Colinas Blvd
Irving, TX 75039

October 22, 2022

7 AM Event Opens
8 AM Opening Ceremony
8 AM Walk

Register Online
https://www.komen.org/dallaswalk

About Susan G. Komen®

Susan G. Komen® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

CONTACT: Amanda Skahan
Susan G. Komen
(972) 855-4388
[email protected]

SOURCE Susan G. Komen for the Cure


These press releases may also interest you

at 06:35
Sage Therapeutics, Inc. and Biogen Inc. announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for zuranolone in the treatment of major depressive disorder (MDD) and...

at 06:35
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the appointment of Bill Meury as president...

at 06:35
The "Growth Opportunities in Onco-Immunotherapy, Genetic Therapy, Synthetic Biology, Microbiome Therapeutics" report has been added to ResearchAndMarkets.com's offering. This edition of the Life Science, Health & Wellness Technology Opportunity...

at 06:30
The increasing trend of outsourcing in several industries related to healthcare domain, such as life sciences, biotech, and pharmaceuticals, is boosting growth within the...

at 06:30
Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, and Hummingbird...

at 06:15
The "Biosimilar Therapeutic Peptides Global Market Report 2022: By Route, By Application, By Type" report has been added to  ResearchAndMarkets.com's offering. The global biosimilar therapeutic peptides market is expected to grow from $0.93 billion...



News published on 22 september 2022 at 15:21 and distributed by: